These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 3923157)
1. Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro. Kelly E; Jenner P; Marsden CD J Neurochem; 1985 Jul; 45(1):137-44. PubMed ID: 3923157 [TBL] [Abstract][Full Text] [Related]
2. Intrastriatal dopaminergic grafts restore inhibitory control over striatal cholinergic neurons. Herman JP; Lupp A; Abrous N; Le Moal M; Hertting G; Jackisch R Exp Brain Res; 1988; 73(2):236-48. PubMed ID: 3145893 [TBL] [Abstract][Full Text] [Related]
3. The effects of dopamine and dopamine agonists on the release of 3H-GABA and 3H-5HT from rat nigral slices. Kelly E; Jenner P; Marsden CD Biochem Pharmacol; 1985 Aug; 34(15):2655-62. PubMed ID: 3925957 [TBL] [Abstract][Full Text] [Related]
4. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine. Roger LJ; Breese GR; Morell P Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743 [TBL] [Abstract][Full Text] [Related]
5. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection. Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137 [TBL] [Abstract][Full Text] [Related]
6. Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons. Baruch P; Artaud F; Godeheu G; Barbeito L; Glowinski J; Chéramy A Neuroscience; 1988 Jun; 25(3):889-98. PubMed ID: 2457187 [TBL] [Abstract][Full Text] [Related]
7. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat. Hall MD; Jenner P; Kelly E; Marsden CD Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246 [TBL] [Abstract][Full Text] [Related]
8. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats. Robertson GS; Damsma G; Fibiger HC J Neurosci; 1991 Jul; 11(7):2209-16. PubMed ID: 1712381 [TBL] [Abstract][Full Text] [Related]
9. Long-term survival of intrastriatal dopaminergic grafts: modulation of acetylcholine release by graft-derived dopamine. Jackisch R; Duschek M; Neufang B; Rensing H; Hertting G; Herman JP J Neurochem; 1991 Jul; 57(1):267-76. PubMed ID: 2051168 [TBL] [Abstract][Full Text] [Related]
10. Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system. Javoy F; Sotelo C; Herbet A; Agid Y Brain Res; 1976 Feb; 102(2):201-15. PubMed ID: 1247882 [TBL] [Abstract][Full Text] [Related]
11. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation. Lindefors N; Brodin E; Tossman U; Segovia J; Ungerstedt U Exp Brain Res; 1989; 74(3):527-34. PubMed ID: 2468514 [TBL] [Abstract][Full Text] [Related]
12. Synaptosomal uptake and release of dopamine in substantia nigra: effects of gamma-aminobutyric acid and substance P. Silbergeld EK; Walters JR Neurosci Lett; 1979 Apr; 12(1):119-26. PubMed ID: 460694 [TBL] [Abstract][Full Text] [Related]
13. Is there a significant somatodendritic uptake of dopamine in the substantia nigra? Evidence from the weaver mutant mouse. Simon JR; Ghetti B Neurochem Int; 1993 May; 22(5):471-7. PubMed ID: 8485453 [TBL] [Abstract][Full Text] [Related]
14. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density. Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504 [TBL] [Abstract][Full Text] [Related]
15. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals. Snyder GL; Keller RW; Zigmond MJ J Pharmacol Exp Ther; 1990 May; 253(2):867-76. PubMed ID: 2110978 [TBL] [Abstract][Full Text] [Related]
16. Different neuronal location of [3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the rat. Savasta M; Dubois A; Benavides J; Scatton B Neurosci Lett; 1986 Dec; 72(3):265-71. PubMed ID: 2950341 [TBL] [Abstract][Full Text] [Related]
17. In vitro characterisation of dopamine receptors in the superior colliculus of the rat. Weller ME; Rose S; Jenner P; Marsden CD Neuropharmacology; 1987 Apr; 26(4):347-54. PubMed ID: 2438586 [TBL] [Abstract][Full Text] [Related]
18. Neurotensin regulation of endogenous acetylcholine release from rat striatal slices is independent of dopaminergic tone. Lapchak PA; Araujo DM; Quirion R; Beaudet A J Neurochem; 1991 Feb; 56(2):651-7. PubMed ID: 1899109 [TBL] [Abstract][Full Text] [Related]
19. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage. Zhang WQ; Tilson HA; Nanry KP; Hudson PM; Hong JS; Stachowiak MK Brain Res; 1988 Oct; 461(2):335-42. PubMed ID: 3141002 [TBL] [Abstract][Full Text] [Related]
20. Sprouting of striatal serotonin nerve terminals following selective lesions of nigro-striatal dopamine neurons in neonatal rat. Luthman J; Bolioli B; Tsutsumi T; Verhofstad A; Jonsson G Brain Res Bull; 1987 Aug; 19(2):269-74. PubMed ID: 3664282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]